The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
2018 · Science · 2,833 citations
https://doi.org/10.1126/science.aao3290
T
Thomas F. Gajewski
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
635
Papers
55.2K
Citations
95
h-index
292
i10-index
Thomas F. Gajewski is an academic researcher from University of Illinois Chicago. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & CAR-T cell therapy research. The author has an h-index of 95, co-authored 540 publications.
ORCID: 0000-0001-5727-3972Papers by this author
worksOncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
2017 · Cell · 1,437 citations
https://doi.org/10.1016/j.cell.2017.08.027
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
2015 · Cell Reports · 1,435 citations
https://doi.org/10.1016/j.celrep.2015.04.031
Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.
1988 · The Journal of Immunology · 838 citations
https://doi.org/10.4049/jimmunol.140.12.4245
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
2018 · Science · 718 citations
https://doi.org/10.1126/science.aar6918
Costimulatory and coinhibitory receptors in anti‐tumor immunity
2009 · Immunological Reviews · 289 citations
https://doi.org/10.1111/j.1600-065x.2009.00771.x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat